Vascular Permeability Assessment

Vascular permeability assessment measures blood vessel wall integrity predicting extravasation risk and drug delivery. Fluorescein leakage quantitates endothelial junction disruption. Albumin extravasation indicates increased permeability. Inflammatory mediators increase permeability transiently. Reversibility assessment determines permanence of changes.

Formulation strategies exploit enhanced permeability. Targeting approaches deliver drugs selectively to leaky vasculature. Regulatory submissions address permeability implications. Post-approval monitoring detects unexpected permeability changes. Clinical outcomes correlate with permeability status.